Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway-Reference-Cited by-同舟云学术

Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway

Published:2012-01 Issue:1 Volume:21 Page:66-81
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Cooke Vesselina G.,LeBleu Valerie S.,Keskin Doruk,Khan Zainab,O'Connell Joyce T.,Teng Yingqi,Duncan Michael B.,Xie Liang,Maeda Genta,Vong Sylvia,Sugimoto Hikaru,Rocha Rafael M.,Damascena Aline,Brentani Ricardo R.,Kalluri Raghu

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference80 articles.

1. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease;Acloque;J. Clin. Invest.,2009

2. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers;Baba;Am. J. Pathol.,2010

3. The role of pericytes in blood-vessel formation and maintenance;Bergers;Neuro-oncol.,2005

4. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors;Bergers;J. Clin. Invest.,2003

5. Met, metastasis, motility and more;Birchmeier;Nat. Rev. Mol. Cell Biol.,2003

Cited by 450 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29

2. Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma;2024-08-27

3. Three-dimensional cell culture conditions promoted the Mesenchymal-Amoeboid Transition in the Triple-Negative Breast Cancer cell line MDA-MB-231;Frontiers in Cell and Developmental Biology;2024-08-02

4. Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach;Journal of Translational Medicine;2024-07-31

5. Pericytes: jack-of-all-trades in cancer-related inflammation;Frontiers in Pharmacology;2024-07-17